Lombardi Cancer Center at Georgetown University — Washington D.C., District of Columbia

Lombardi Cancer Center at Georgetown University is a clinical research site located in Washington D.C., District of Columbia, United States 20007.

Crixeo Health Trust Score: 41/100 (POOR). This profile has not yet been claimed by the site owner.

Lombardi Cancer Center at Georgetown University has participated in 1 clinical trials.

Therapeutic areas: Metastatic Colorectal Cancer.

Sponsors: Georgetown University.

Sponsor Feasibility Report

Trust Score: 41/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Lombardi Cancer Center at Georgetown University?

Lombardi Cancer Center at Georgetown University has a Crixeo Trust Score of 41/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Lombardi Cancer Center at Georgetown University conducted?

Lombardi Cancer Center at Georgetown University has 1 clinical trials on record. Their work covers Metastatic Colorectal Cancer.

Is Lombardi Cancer Center at Georgetown University accredited by Crixeo Health?

Lombardi Cancer Center at Georgetown University has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Lombardi Cancer Center at Georgetown University?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.